PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+54.17%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$347M
AUM Growth
+$347M
(+61%)
Cap. Flow
+$61.9M
Cap. Flow
% of AUM
17.87%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
89
New
22
Increased
24
Reduced
19
Closed
10
Top Buys
| 1 |
Humana
HUM
|
$11.6M |
| 2 |
Danaher
DHR
|
$8.84M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$8.83M |
| 4 |
Edwards Lifesciences
EW
|
$8.29M |
| 5 |
AbbVie
ABBV
|
$7.36M |
Top Sells
| 1 |
Merck
MRK
|
$6.96M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$6.63M |
| 3 |
Schrodinger
SDGR
|
$5.96M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$4.77M |
| 5 |
Intuitive Surgical
ISRG
|
$4.49M |
Sector Composition
| 1 | Healthcare | 91.97% |
| 2 | Technology | 0.91% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Madrigal Pharmaceuticals
MDGL
$9.7B
| $5.66M | 1.6% |
50,000
+20,000
| +67% | +$2.27M |
|
|
XLRN
27
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.48M | 1.54% |
57,500
+20,000
| +53% | +$1.91M |
|
28
Alnylam Pharmaceuticals
ALNY
$58.6B
| $5.31M | 1.5% |
35,863
-500
| -1% | -$74.1K |
|
|
ITMR
29
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $5.22M | 1.47% |
280,650
+15,000
| +6% | +$279K |
|
|
SILK
30
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $5.03M | 1.42% |
120,000
-15,000
| -11% | -$628K |
|
|
MTEM
31
DELISTED
Molecular Templates, Inc.
MTEM
| $4.73M | 1.33% |
342,875
| – | – |
|
32
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.29M | 1.21% |
900,608
-95,000
| -10% | -$453K |
|
33
Arcus Biosciences
RCUS
$1.24B
| $3.96M | 1.12% |
+160,000
| New | +$3.96M |
|
|
KDMN
34
DELISTED
Kadmon Holdings, Inc.
KDMN
| $3.71M | 1.05% |
+725,000
| New | +$3.71M |
|
35
Kodiak Sciences
KOD
$453M
| $3.53M | 0.99% |
65,218
| – | – |
|
36
Insulet
PODD
$24.2B
| $3.4M | 0.96% |
+17,500
| New | +$3.4M |
|
37
Novavax
NVAX
$1.2B
| $3.33M | 0.94% |
+40,000
| New | +$3.33M |
|
|
TECX
38
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $3.33M | 0.94% |
190,593
-105,000
| -36% | -$1.83M |
|
39
Axsome Therapeutics
AXSM
$6.09B
| $3.29M | 0.93% |
+40,000
| New | +$3.29M |
|
|
NUAN
40
DELISTED
Nuance Communications, Inc.
NUAN
| $3.17M | 0.89% |
125,056
-25,000
| -17% | -$633K |
|
41
Immunovant
IMVT
$2.91B
| $3.05M | 0.86% |
125,125
+85,000
| +212% | +$2.07M |
|
42
Stereotaxis
STXS
$246M
| $2.98M | 0.84% |
668,693
+15,000
| +2% | +$66.9K |
|
43
KALA BIO
KALA
$105M
| $2.89M | 0.81% |
275,000
+50,000
| +22% | +$525K |
|
44
Aclaris Therapeutics
ACRS
$223M
| $2.75M | 0.77% |
1,697,357
+160,000
| +10% | +$259K |
|
45
Haemonetics
HAE
$2.57B
| $2.7M | 0.76% |
30,147
+15,000
| +99% | +$1.34M |
|
|
SPNE
46
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.57M | 0.72% |
245,785
| – | – |
|
47
InfuSystem Holdings
INFU
$215M
| $2.49M | 0.7% |
215,483
+45,000
| +26% | +$519K |
|
48
BridgeBio Pharma
BBIO
$9.91B
| $2.45M | 0.69% |
75,215
| – | – |
|
|
TRIL
49
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.43M | 0.68% |
300,000
-125,000
| -29% | -$1.01M |
|
50
Akero Therapeutics
AKRO
$3.65B
| $2.37M | 0.67% |
+95,000
| New | +$2.37M |
|